Lancet

Tackling the global health research financing emergency to sustain national health research ecosystems.Rasanathan, K. Compaoré, R. Chopra, M. El-Jardali, F. Ghaffar, A. Happi, C. Kariuki, T. Knezovich, J. Mirzoev, T. Moon, S. Ntusi, N. A. B. Ohiri, K. Ramani, S. Ren, M. Saminarsih, D. Saphonn, V. Schneider, H. Srinivas, P. N. Swaminathan, S. Tsofa, B. Wanyenze, R. K. Røttingen, J. A.
Lancet, (2026). 407:1485-1488

Low-dose yellow fever vaccination in infants: a randomised, double-blind, non-inferiority trial.Kimathi, D. Juan-Giner, A. Bob, N. S. Orindi, B. Namulwana, M. L. Diatta, A. Cheruiyot, S. Fall, G. Dia, M. Hamaluba, M. M. Nyehangane, D. Karanja, H. K. Gitonga, J. N. Mugo, D. Omuoyo, D. O. Hussein, M. Oloo, E. Kamau, N. Wafula, J. Bendera, J. Silvester, N. Mwavita, J. Joshua, M. Thuranira, J. M. Agababyona, C. Ngetsa, C. Aisha, N. Moki, F. Buluku, T. Munene, M. Mwanga-Amumpaire, J. Lutwama, J. Kayiwa, J. Kamaara, E. Barrett, A. D. Kaleebu, P. Bejon, P. Sall, A. A. Grais, R. F. Warimwe, G. M.
Lancet, (2026). 407:497-504

Global age-sex-specific all-cause mortality and life expectancy estimates for 204 countries and territories and 660 subnational locations, 1950-2023: a demographic analysis for the Global Burden of Disease Study 2023.G. B. D. Demographics Collaborators
Lancet, (2025). 406:1731-1810

Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.G. B. D. Disease Injury, Risk Factor, Collaborators
Lancet, (2025). 406:1873-1922

Integrating gender and equity commitments in the revised global action plan on antimicrobial resistance.Batheja, D. Saint, V. Dobreva, Z. Goel, S. Lewycka, S. Mutua, E. Nayiga, S. Paulin-Deschenaux, S. Simpson, S. J. Steege, R. Westwood, E. Charani, E. Mpundu, M. Balachandran, A.
Lancet, (2025). 406:1200-1203

A multifaceted intervention to improve diagnosis and early management of hospitalised patients with suspected acute brain infections in Brazil, India, and Malawi: an international multicentre intervention study.Singh, B. Lipunga, G. D. Thangavelu, P. Dhar, S. Ferreira Cronemberger, L. Abhilash, K. P. P. Abraham, A. M. de Brito, C. A. A. Brito Ferreira, M. L. Chandrashekar, N. Duarte, R. Fajardo Modol, A. Ghale, B. C. Kang, G. Gowda, V. K. Kuriakose, K. Lant, S. Mallewa, M. Mbale, E. Moore, S. C. Mwangalika, G. Kamath, P. B. T. Navvuga, P. Nyondo-Mipando, A. L. Phiri, T. J. Pimentel Lopes de Melo, C. Pradeep, B. S. Rawlinson, R. Sheha, I. Thomas, P. T. Newton, C. R. de Sequeira, P. C. Sejvar, J. J. Dua, T. Turtle, L. Verghese, V. P. Arraes, Lwms Desmond, N. Easton, A. Jones, J. A. Lilford, R. J. Netravathi, M. McGill, F. Michael, B. D. Mwapasa, V. Griffiths, M. J. Parry, C. M. Ravi, V. Burnside, G. Brain Infections Global Intervention Study, Group Cornick, J. Franca, R. F. O. Desai, A. S. Rupali, P. Solomon, T.
Lancet, (2025). 405:991-1003

Regional action needed to halt antimalarial drug resistance in Africa.Martinez-Vega, R. Ishengoma, D. S. Gosling, R. Rosenthal, P. J. Dondorp, A. Barnes, K. I. Nsanzabana, C. Djimde, A. A. Ochola-Oyier, L. I. Tibenderana, J. Chimumbwa, J. Golassa, L. Kapologwe, N. A. Mbacham, W. F. Kamya, M. R. Fidock, D. A. Komatsu, R. von Seidlein, L. Dhorda, M.
Lancet, (2025). 405:7-10

Differentiating mortality risk of individual infants and children to improve survival: opportunity for impact.Berkley, J. A. Walson, J. L. Bahl, R. Rollins, N.
Lancet, (2024). 404:492-494

Feasibility, safety, and impact of the RTS,S/AS01(E) malaria vaccine when implemented through national immunisation programmes: evaluation of cluster-randomised introduction of the vaccine in Ghana, Kenya, and Malawi.Asante, K. P. Mathanga, D. P. Milligan, P. Akech, S. Oduro, A. Mwapasa, V. Moore, K. A. Kwambai, T. K. Hamel, M. J. Gyan, T. Westercamp, N. Kapito-Tembo, A. Njuguna, P. Ansong, D. Kariuki, S. Mvalo, T. Snell, P. Schellenberg, D. Welega, P. Otieno, L. Chimala, A. Afari, E. A. Bejon, P. Maleta, K. Agbenyega, T. Snow, R. W. Zulu, M. Chinkhumba, J. Samuels, A. M. Malaria Vaccine Programme Evaluation, Partners
Lancet, (2024). 403:1660-1670

Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950-2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021.G. B. D. Demographics Collaborators
Lancet, (2024). 403:1989-2056

Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial.Datoo, M. S. Dicko, A. Tinto, H. Ouedraogo, J. B. Hamaluba, M. Olotu, A. Beaumont, E. Ramos Lopez, F. Natama, H. M. Weston, S. Chemba, M. Compaore, Y. D. Issiaka, D. Salou, D. Some, A. M. Omenda, S. Lawrie, A. Bejon, P. Rao, H. Chandramohan, D. Roberts, R. Bharati, S. Stockdale, L. Gairola, S. Greenwood, B. M. Ewer, K. J. Bradley, J. Kulkarni, P. S. Shaligram, U. Hill, A. V. S. R. 1/Matrix-M Phase 3 Trial Group
Lancet, (2024). 403:533-544

How modelling can better support public health policy making: the Lancet Commission on Strengthening the Use of Epidemiological Modelling of Emerging and Pandemic Infectious Diseases.Lancet Commission on Strengthening the Use of Epidemiological Modelling of, Emerging Pandemic Infectious Diseases. Electronic address, mark jit lshtm ac uk
Lancet, (2024). 403:789-791

Learning from serosurveillance for SARS-CoV-2 to inform pandemic preparedness and response.Public Health Collaborators on Serosurveillance for Pandemic, Preparedness Response, PHSeroPPR
Lancet, (2023). 402:356-358

Intersectional insights into racism and health: not just a question of identity.Shannon, G. Morgan, R. Zeinali, Z. Brady, L. Couto, M. T. Devakumar, D. Eder, B. Karadag, O. Mukherjee, M. Peres, M. F. T. Ryngelblum, M. Sabharwal, N. Schonfield, A. Silwane, P. Singh, D. Van Ryneveld, M. Vilakati, S. Watego, C. Whyle, E. Muraya, K.
Lancet, (2022). 400:2125-2136

Executive summary.Devakumar, D. Abubakar, I. Tendayi Achiume, E. Muraya, K. Paradies, Y. Saini, A. Selvarajah, S. Shannon, G.
Lancet, (2022). 400:2095-2096

Substantial misdiagnosis of severe malaria in African children.White, N. J. Watson, J. A. Uyoga, S. Williams, T. N. Maitland, K. M.
Lancet, (2022). 400:807

Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis.Li, Y. Wang, X. Blau, D. M. Caballero, M. T. Feikin, D. R. Gill, C. J. Madhi, S. A. Omer, S. B. Simoes, E. A. F. Campbell, H. Pariente, A. B. Bardach, D. Bassat, Q. Casalegno, J. S. Chakhunashvili, G. Crawford, N. Danilenko, D. Do, L. A. H. Echavarria, M. Gentile, A. Gordon, A. Heikkinen, T. Huang, Q. S. Jullien, S. Krishnan, A. Lopez, E. L. Markic, J. Mira-Iglesias, A. Moore, H. C. Moyes, J. Mwananyanda, L. Nokes, D. J. Noordeen, F. Obodai, E. Palani, N. Romero, C. Salimi, V. Satav, A. Seo, E. Shchomak, Z. Singleton, R. Stolyarov, K. Stoszek, S. K. von Gottberg, A. Wurzel, D. Yoshida, L. M. Yung, C. F. Zar, H. J. Respiratory Virus Global Epidemiology, Network Nair, H. Resceu investigators
Lancet, (2022). 399:2047-2064

The Lancet Nigeria Commission: investing in health and the future of the nation.Abubakar, I. Dalglish, S. L. Angell, B. Sanuade, O. Abimbola, S. Adamu, A. L. Adetifa, I. M. O. Colbourn, T. Ogunlesi, A. O. Onwujekwe, O. Owoaje, E. T. Okeke, I. N. Adeyemo, A. Aliyu, G. Aliyu, M. H. Aliyu, S. H. Ameh, E. A. Archibong, B. Ezeh, A. Gadanya, M. A. Ihekweazu, C. Ihekweazu, V. Iliyasu, Z. Kwaku Chiroma, A. Mabayoje, D. A. Nasir Sambo, M. Obaro, S. Yinka-Ogunleye, A. Okonofua, F. Oni, T. Onyimadu, O. Pate, M. A. Salako, B. L. Shuaib, F. Tsiga-Ahmed, F. Zanna, F. H.
Lancet, (2022). 399:1155-1200

Population health outcomes in Nigeria compared with other west African countries, 1998-2019: a systematic analysis for the Global Burden of Disease Study.Angell, B. Sanuade, O. Adetifa, I. M. O. Okeke, I. N. Adamu, A. L. Aliyu, M. H. Ameh, E. A. Kyari, F. Gadanya, M. A. Mabayoje, D. A. Yinka-Ogunleye, A. Oni, T. Jalo, R. I. Tsiga-Ahmed, F. I. Dalglish, S. L. Abimbola, S. Colbourn, T. Onwujekwe, O. Owoaje, E. T. Aliyu, G. Aliyu, S. H. Archibong, B. Ezeh, A. Ihekweazu, C. Iliyasu, Z. Obaro, S. Obadare, E. B. Okonofua, F. Pate, M. Salako, B. L. Zanna, F. H. Glenn, S. Walker, A. Ezalarab, M. Naghavi, M. Abubakar, I.
Lancet, (2022). 399:1117-1129

Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.Antimicrobial Resistance, Collaborators
Lancet, (2022). 399:629-655